Purchase Order N6890818P0101

This is a $12,454.17 firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of OMNIPOD 5 DEXG7G6 PODS (GEN 5), a medical device used for diabetes management, with an ultimate completion date of July 18, 2025. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...

The Defense Logistics Agency (DLA) awarded a delivery order valued at $33,926.33 to AmerisourceBergen Drug Corp for OmniPod 5 DEXG7G6 Pods (Generation 5) 5S, medical devices used in diabetes management. The contract, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, utilizes firm fixed pricing and was awarded on a competitive basis without a set-aside designation. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...

The Defense Logistics Agency awarded a delivery order valued at $5,177.01 to AmerisourceBergen Drug Corp for OmniPod 5 Dexcom G7 Generation 5 pods, with performance in Conshohocken, Pennsylvania and completion expected by January 28, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a task order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026....

The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,456.35 to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5) with a completion date of October 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an existing contract vehicle. The products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate operations. OmniPod 5 pods represent...

The Defense Logistics Agency awarded a $50,053.45 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 continuous glucose monitoring system pods (Generation 5) with a completion date of December 31, 2025. This non-set-aside, firm fixed-price contract represents a competitively awarded delivery order for specialized medical devices supporting diabetes management needs within the federal healthcare supply chain. The place of performance is AmerisourceBergen's corporate office location in...

The Defense Logistics Agency awarded a $19,044.18 delivery order to AmerisourceBergen Drug Corp for OmniPod 5 DexG7G6 Pods (Generation 5), 5-pack units on August 26, 2025, with an ultimate completion date of August 27, 2025. This firm fixed-price contract was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a specialized medical device procurement for...

This federal contract award, valued at $1,790.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OMNIPOD 5 DEXG7G6 PODS (GEN 5) 5S, a medical device, with a completion date of February 13, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...

This federal contract award to Zoll Medical Corporation, a foreign-owned, for-profit manufacturer of medical devices, is for the delivery of "LIFE VEST" with a ceiling value of $14,400.00. The contract is a Purchase Order with a Firm Fixed Price pricing type and an ultimate completion date of November 5, 2023. The awarding agency is the Veterans Integrated Service Network 16, a civilian agency within the Department of Veterans Affairs (VA). Zoll Medical Corporation, doing business as...

The Defense Logistics Agency awarded a delivery order valued at $1,774.98 to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 22, 2026, with an ultimate completion date of January 23, 2026. The order is for OmniPod 5 Dexcom G7 pods (Generation 5) in 5-count packages, which are continuous glucose monitoring and insulin delivery devices used for diabetes management. This competitively awarded, non-set-aside delivery order employs firm fixed-price pricing and will be performed at the...

This is a firm-fixed-price purchase order awarded by the U.S. Department of Veterans Affairs (VA) to Zoll Services LLC, a foreign-owned, for-profit subsidiary of ZOLL Medical Corporation. The $10,800.00 contract is for the provision of PROS - LIFE VEST, a medical device product line focused on emergency cardiac care. The contract has an ultimate completion date of September 25, 2025 and does not have a set-aside designation, indicating Zoll Services LLC competed openly for this award. Zoll...